Clinical Trial Update: Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial update on the efficacy of 5-Aza as post-remission therapy for elderly patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• 5-Aza (azacitidine)

Snippet

Sponsor: Associazione Qol-one | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED